 |
Gangliosides as sodium salts |
|---|---|
| Trade Name | Cronassial |
| Orphan Indication | Retinitis pigmentosa |
| USA Market Approval | USA |
| USA Designation Date | 1988-11-17 00:00:00 |
| Sponsor | Fidia Pharmaceutical Corp.;1401 Eye Street, N.W. Suite 900;Washington, District of Columbia, 20005 |
